Delivery Order SPE2DB25D3017-SPE2DB25FVKSV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,677.02 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg, a diabetes medication. This competitively awarded, firm fixed-price delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025, and carries no set-aside designation. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $7,108.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 25 mg, a diabetes medication. The contract was competitively awarded without set-aside designation and has an ultimate completion date of August 11, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply delivery. This delivery order is issued under...
- The Defense Logistics Agency awarded a $7,691.02 delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 25 mg, a diabetes medication. The contract was competitively awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $11,924.99 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 10 mg, a diabetes management medication. The contract was competitively awarded without set-aside designation and carries a firm fixed-price structure with an ultimate completion date of August 5, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This delivery order is...
- The Defense Logistics Agency awarded a $15,581.90 delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 25 mg, a diabetes medication. The contract was competitively awarded without set-aside restrictions under a firm fixed-price arrangement, with an ultimate completion date of September 10, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $11,472.94 delivery order to AmerisourceBergen Drug Corp for 90-count supplies of Jardiance 25 mg tablets, a diabetes medication. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 28, 2025. AmerisourceBergen will perform the delivery from its corporate office in Conshohocken, Pennsylvania, where the company maintains its primary headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,987.19 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 10 mg, a diabetes medication. The contract, awarded on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open competition. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $11,482.71 to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 10 mg, a diabetes medication. This firm fixed price delivery order, awarded on September 12, 2025, with a completion date of September 15, 2025, was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,957.32 delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 25 mg, a diabetes medication. This competitive, non-set-aside award was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and represents a firm fixed-price transaction under a child delivery order structure. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $7,810.13 to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 10 mg, a diabetes medication. The contract is competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of September 17, 2025. This delivery order represents performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, which serves as the company's corporate headquarters and a...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB25FVKSVDelivery Order
The Defense Logistics Agency awarded a $7,177.68 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg, a diabetes medication. The contract is a firm fixed price delivery order with an ultimate completion date of September 22, 2025, and represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs and other federal medical systems worldwide. The underlying IDC demonstrates AmerisourceBergen's established capability as a critical pharmaceutical distributor for federal medical procurement needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 9/19/25 |